Lophius Biosciences Closes Financing Round To Set New Standard In Tuberculosis Diagnosis
Lophius Biosciences GmbH today announced that the company has closed a financing round of €3.1m led by VRD GmbH, support…
Lophius Biosciences GmbH today announced that the company has closed a financing round of €3.1m led by VRD GmbH, support…
Lophius Biosciences GmbH today announced that the company has achieved an important development milestone for its propri…
Lophius Biosciences GmbH today announced successful top-line results from its multicenter AlloProtect CMV clinical study…
Lophius Biosciences GmbH today announced the publication of a peer-reviewed scientific paper covering the company’s CE-m…
Lophius Biosciences GmbH and Mediphos Medical Supplies B.V. today announced their distribution partnership for the in vi…
Lophius Biosciences GmbH today announced the launch of the next generation of its in vitro diagnostic test T-Track® CMV…
Lophius Biosciences GmbH today announced that it has been awarded a public grant funding of 0.65 MEUR from the German Fe…
Lophius Biosciences GmbH today announced the publication of two peer-reviewed scientific papers covering the company’s C…
Lophius Biosciences GmbH, a privately held biotech company focusing on the development and marketing of innovative T cel…
Lophius Biosciences GmbH today announced the extension of the first tranche of the recently closed financing round by €5…